We are pleased to announce that Evidilya has participated as CRO in a multinational study aimed at evaluating the psychometric properties of the RAPP, a validated tool of 8 questions that provides evaluation of HRQoL of patients with asthma and/or rhinitis in clinical practice, in 5 countries (Spain, France, Portugal, Poland and the Philippines) and compares HRQoL in the countries involved.

Three country-wise study are already available:

– https://www.ncbi.nlm.nih.gov/pubmed/31601503

– https://www.ncbi.nlm.nih.gov/pubmed/30907184

– https://www.ncbi.nlm.nih.gov/pubmed/30737172

The results have clearly confirmed that the RAPP country version has good measurement properties and sensitivity to health changes, which will provide a valid, reliable and standardized HRQoL measurement in patients with asthma and comorbid allergic rhinitis in clinical practice.